well, yes it seemed to be a promo for his new, super expensive newsletter. He was also talking about STSI which is now called 'rock creek pharma' . Briefly mentioned the political problems overcome. but Patrick of course never mentioned how the share price Collapsed to multiyear lows and is just now starting to recover. Just like BTX.
Patrick's picks have been a very mixed bag. in these last 5 years Ive been following him. He's very persuasive, its easy to end up buying every pick he recommends.
All with scant focus on concerning political issues , governmental problems, moral or ethical concerns, etc....and especially what the market does in collapsing the share price of these stocks ... so often .
Look at ISCO as an example. look at ISCO chart since 2008... Patrick loved this company. crowed with high praise to no end, about ISCO.
All thru the peak and the collapse, singing high praise and recommending it as a big buy. all the way up and all the way down.
an I drank the PC kool aid. and with BTX as well.
This video from Patrick is his fresh jug of same old kool aid.
which doesn't mean to say that companies research isn't moving forward successfully...and maybe finally the share price can rally better than 4 years ago...or maybe share price can return to where it was 2 years ago,maybe investors can recover their losses , maybe new investors can make gains. maybe the technology is going to be sucessful....but the promotion was singing high praise exactly like this 4 years ago. To me its the same kool aid that lost me a lot of money so far.I guess it means Patrick's picks were 5 years too early ,5 years ago.
Patrick's picks have been a very mixed bag. in these last 5 years Ive been following him. He's very persuasive, its easy to end up buying every pick he recommends.
All with scant focus on concerning political issues , governmental problems, moral or ethical concerns, etc....and especially what the market does in collapsing the share price of these stocks ... so often .
Look at ISCO as an example. look at ISCO chart since 2008... Patrick loved this company. crowed with high praise to no end, about ISCO.
All thru the peak and the collapse, singing high praise and recommending it as a big buy. all the way up and all the way down.
an I drank the PC kool aid. and with BTX as well.
This video from Patrick is his fresh jug of same old kool aid.
which doesn't mean to say that companies research isn't moving forward successfully...and maybe finally the share price can rally better than 4 years ago...or maybe share price can return to where it was 2 years ago,maybe investors can recover their losses , maybe new investors can make gains. maybe the technology is going to be sucessful....but the promotion was singing high praise exactly like this 4 years ago. To me its the same kool aid that lost me a lot of money so far.I guess it means Patrick's picks were 5 years too early ,5 years ago.
Recent LCTX News
- Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease • Business Wire • 03/24/2026 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/24/2026 04:15:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 08:05:10 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/11/2026 01:00:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 01:00:26 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/11/2026 01:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2026 12:51:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2026 12:50:33 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:10:24 PM
- Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update • Business Wire • 03/05/2026 09:01:00 PM
- Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026 • Business Wire • 02/26/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 12:30:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2026 12:30:03 AM
- Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience • Business Wire • 01/06/2026 01:00:00 PM
- Lineage Cell Therapeutics Issues Letter to Stockholders • Business Wire • 01/05/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2025 02:55:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2025 02:55:03 AM
- Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy • PR Newswire (Canada) • 12/16/2025 04:53:00 PM
- Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy • PR Newswire (US) • 12/16/2025 04:53:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2025 09:05:24 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 11/14/2025 11:12:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 02:25:41 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/12/2025 02:15:17 PM
